Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VALSARTAN vs VANDETANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VALSARTAN vs VANDETANIB: Safety Overview

Metric VALSARTAN VANDETANIB
Total FAERS Reports 21,720 1,159
Deaths Reported 1,696 93
Death Rate 7.8% 8.0%
Hospitalizations 7,746 363
Average Patient Age 67.1 yrs 53.6 yrs
% Female Patients 58.1% 54.8%
FDA Approval Date Apr 9, 2018 Apr 6, 2011
Manufacturer Jubilant Cadista Pharmacuticals Inc. Genzyme Corporation
Route ORAL ORAL
Marketing Status Discontinued Prescription